Eurazeo, Ardian, Mérieux sell stakes in Humens

Humens is a high-purity mineral-based specialty products producer.

  • Humens supplies supplies sodium bicarbonate to the pharmaceuticals, cosmetics and agri-food industries
  • The proceeds for Eurazeo’s balance sheet amount to €33 million
  • The buyer is Leto Partners

Eurazeo and its partners Ardian, Mérieux Equity Partners and Eximium have sold their stakes in Humens to Leto Partners.

The equity investment by Eurazeo has generated a cash-on-cash multiple of 2.7x and an internal rate of return 65 percent since the carve-out from Seqens’ group in 2021. The proceeds for Eurazeo’s balance sheet amount to €33 million.

Humens is a high-purity mineral-based specialty products producer. It mainly supplies sodium bicarbonate to the pharmaceuticals, cosmetics and agri-food industries.

“We are proud to have supported the management of Humens in the implementation of a shared strategy, which has led to a geographic expansion in Asia with the construction of a greenfield sodium bicarbonate plant in Singapore, and two major investments in the energy transition,” said Wilfried Piskula, managing director, mid-large buyout, Eurazeo.

Eurazeo is a European investment group with €33.5 billion in diversified assets under management. The firm is based in Paris.

Ardian is a private investment firm that manages $156 billion of assets. It is based in Paris.

Mérieux Equity Partners is a healthcare focused private equity firm based in Paris.